Sarcoidosis Board decisions

The Board granted service connection for sarcoidosis, which manifested to a compensable degree within one year of the Veteran's separation from service. The claims for lupus and rheumatoid arthritis were remanded for further development.

The case is remanded to obtain a more thorough medical opinion regarding the Veteran's death and whether his service, including exposure to herbicides in Thailand, caused or triggered pulmonary sarcoidosis.

The veteran withdrew his appeal for service connection for shortness of breath before the Board made a decision.

The Board granted entitlement to Special Monthly Compensation (SMC) based on blindness in both eyes and remanded the issue of service connection for sarcoidosis due to a pre-decisional duty-to-assist error.

The Board denied service connection for abnormal heart chest pains, bronchitis, COPD, pleuritis, and sarcoidosis as there was no evidence of a current diagnosis. The Board also denied an initial rating in excess of 30 percent for PTSD with alcohol use disorder.

The Board granted service connection for hypertension, Parkinson's disease, cryptococcal infection, and sarcoidosis as secondary to the cryptococcal infection. COPD was also granted as secondary to both cryptococcal infection and Parkinson's disease.

The Board denied an effective date earlier than August 10, 2022, for the grant of a 60 percent rating for sarcoidosis, asthma, chronic bronchitis, and COPD.

The Board denied service connection for the cause of the Veteran's death, finding no evidence linking his death to any period of service or presumed exposure to contaminated water at Camp LeJeune.

The Board remands the claims for service connection for sarcoidosis and related conditions, as well as secondary service connection claims, due to an inadequate VA opinion regarding the etiology of the Veteran's sarcoidosis.

The Board remands the matter for a new medical examination to address the Veteran's claim for service connection for sarcoidosis, as the previous VA medical opinions did not adequately connect the Veteran's in-service symptoms with his current condition.

The Board granted service connection for sarcoidosis and necrobiotic granulomata under the PACT Act, but remanded claims for compensable evaluations of surgical scars.

The Board remands the claims for service connection for 12 respiratory conditions due to a need for additional medical evidence and examinations.

The Board denied service connection for sarcoidosis and interstitial lung disease, as the evidence did not support a finding that these conditions were related to the Veteran's military service.

The Board granted service connection for right knee degenerative arthritis and denied initial compensable ratings for sarcoidosis, a scar, status post left ankle surgery, and remanded several other claims.

The Board denied service connection for lumbar spine, right leg, and acquired psychiatric disorder due to lack of new and relevant evidence. Sarcoidosis and sarcoidosis arthritis were also denied as there was no medical evidence linking them to the Veteran's service.

The appeal for service connection for sarcoidosis is dismissed as the benefit has been granted in full.

The Board dismissed the veteran's appeals for service connection for chronic lung abscess and sarcoidosis due to an untimely Notice of Disagreement.

The Board granted an initial rating of 30 percent for sarcoidosis, as the Veteran's condition manifests with pulmonary involvement and persistent symptoms requiring intermittent corticosteroids.

The Board remands the claims for an earlier effective date and to obtain medical opinions on whether the Veteran's sleep apnea is secondary to his sarcoidosis, and whether his peripheral neuropathy of the bilateral upper and lower extremities are due to his service-connected sarcoidosis.

The Board granted service connection for sarcoidosis on a direct basis, effective August 10, 2022.